OpenAI's Wild Week: A Custom Chip, 40% of the World's DRAM, and a $500 Million Bet to Kill the Common Cold

OpenAI is described as evolving beyond a model lab into a vertically integrated AI platform pursuing its own silicon and greater control over memory supply. The piece frames this as an expansion of strategic ambition, including efforts to cure the common cold, but provides no hard financial figures or near-term operating metrics. The tone is broadly positive on long-term innovation potential, though the article is mostly conceptual rather than price-moving.

Analysis

OpenAI is described as evolving beyond a model lab into a vertically integrated AI platform pursuing its own silicon and greater control over memory supply. The piece frames this as an expansion of strategic ambition, including efforts to cure the common cold, but provides no hard financial figures or near-term operating metrics. The tone is broadly positive on long-term innovation potential, though the article is mostly conceptual rather than price-moving.